Cargando…

Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study

Detalles Bibliográficos
Autores principales: Freedberg, Daniel E., Conigliaro, Joseph, Wang, Timothy C., Tracey, Kevin J., Callahan, Michael V., Abrams, Julian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242191/
https://www.ncbi.nlm.nih.gov/pubmed/32446698
http://dx.doi.org/10.1053/j.gastro.2020.05.053
_version_ 1783537191000997888
author Freedberg, Daniel E.
Conigliaro, Joseph
Wang, Timothy C.
Tracey, Kevin J.
Callahan, Michael V.
Abrams, Julian A.
author_facet Freedberg, Daniel E.
Conigliaro, Joseph
Wang, Timothy C.
Tracey, Kevin J.
Callahan, Michael V.
Abrams, Julian A.
author_sort Freedberg, Daniel E.
collection PubMed
description
format Online
Article
Text
id pubmed-7242191
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher by the AGA Institute
record_format MEDLINE/PubMed
spelling pubmed-72421912020-05-22 Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study Freedberg, Daniel E. Conigliaro, Joseph Wang, Timothy C. Tracey, Kevin J. Callahan, Michael V. Abrams, Julian A. Gastroenterology Brief Communication by the AGA Institute 2020-09 2020-05-22 /pmc/articles/PMC7242191/ /pubmed/32446698 http://dx.doi.org/10.1053/j.gastro.2020.05.053 Text en © 2020 by the AGA Institute. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Brief Communication
Freedberg, Daniel E.
Conigliaro, Joseph
Wang, Timothy C.
Tracey, Kevin J.
Callahan, Michael V.
Abrams, Julian A.
Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
title Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
title_full Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
title_fullStr Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
title_full_unstemmed Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
title_short Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
title_sort famotidine use is associated with improved clinical outcomes in hospitalized covid-19 patients: a propensity score matched retrospective cohort study
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242191/
https://www.ncbi.nlm.nih.gov/pubmed/32446698
http://dx.doi.org/10.1053/j.gastro.2020.05.053
work_keys_str_mv AT freedbergdaniele famotidineuseisassociatedwithimprovedclinicaloutcomesinhospitalizedcovid19patientsapropensityscorematchedretrospectivecohortstudy
AT conigliarojoseph famotidineuseisassociatedwithimprovedclinicaloutcomesinhospitalizedcovid19patientsapropensityscorematchedretrospectivecohortstudy
AT wangtimothyc famotidineuseisassociatedwithimprovedclinicaloutcomesinhospitalizedcovid19patientsapropensityscorematchedretrospectivecohortstudy
AT traceykevinj famotidineuseisassociatedwithimprovedclinicaloutcomesinhospitalizedcovid19patientsapropensityscorematchedretrospectivecohortstudy
AT callahanmichaelv famotidineuseisassociatedwithimprovedclinicaloutcomesinhospitalizedcovid19patientsapropensityscorematchedretrospectivecohortstudy
AT abramsjuliana famotidineuseisassociatedwithimprovedclinicaloutcomesinhospitalizedcovid19patientsapropensityscorematchedretrospectivecohortstudy
AT famotidineuseisassociatedwithimprovedclinicaloutcomesinhospitalizedcovid19patientsapropensityscorematchedretrospectivecohortstudy